↓ Skip to main content

Managing Atopic Dermatitis with Lebrikizumab – The Evidence to Date

Overview of attention for article published in Clinical, Cosmetic and Investigational Dermatology, June 2022
Altmetric Badge

Readers on

mendeley
38 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Managing Atopic Dermatitis with Lebrikizumab – The Evidence to Date
Published in
Clinical, Cosmetic and Investigational Dermatology, June 2022
DOI 10.2147/ccid.s295672
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 38 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 4 11%
Other 3 8%
Student > Bachelor 3 8%
Professor 1 3%
Student > Ph. D. Student 1 3%
Other 2 5%
Unknown 24 63%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 5 13%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Biochemistry, Genetics and Molecular Biology 2 5%
Nursing and Health Professions 1 3%
Agricultural and Biological Sciences 1 3%
Other 3 8%
Unknown 24 63%